Androgens
The therapeutically useful androgens are synthetic derivatives of naturally occurring
testosterone. They include:
·
fluoxymesterone
·
testolactone
·
testosterone enanthate
·
testosterone propionate.
The pharmacokinetic properties of therapeutic
androgens resem-ble those of naturally occurring testosterone.
The oral androgens—fluoxymesterone and
testolactone—are well absorbed. The parenteral ones—testosterone enanthate and
testosterone propionate—are designed specifically for slow ab-sorption after
I.M. injection.
Androgens are well distributed throughout the
body, metabolized extensively in the liver, and excreted in urine.
The duration of the parenteral forms is longer
because the oil sus-pension is absorbed slowly. Parenteral androgens are
adminis-tered one to three times per week.
Androgens probably act by one or more mechanisms.
They may reduce the number of prolactin receptors or may bind competi-tively to
those that are available.
Androgens may inhibit estrogen synthesis or
competitively bind at estrogen receptors. These actions prevent estrogen from
affect-ing estrogen-sensitive tumors.
Androgens are indicated for the palliative
treatment of advanced breast cancer, particularly in postmenopausal women with
bone metastasis.
Androgens may alter dose requirement in patients
receiving in-sulin, oral antidiabetic drugs, or oral anticoagulants. Taking
them with drugs that are toxic to the liver increases the risk of liver
tox-icity. (See Adverse reactions to
androgens.)
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.